Breast cancer surveillance following ovarian cancer in BRCA mutation carriers
CONCLUSIONS: Ten percent of women developed BC after EOC. The incidence of BC following EOC in BRCA carriers increases over time, and surveillance is recommended given their enhanced survival of EOC. Timely genetic testing for women with EOC is imperative to better triage BC screening resources and treatment.PMID:34862065 | DOI:10.1016/j.ygyno.2021.10.077
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Catherine S John Abigail Fong Rodrigo Alban Jessica Gillen Kathleen M Moore Christine S Walsh Andrew J Li B J Rimel Farin Amersi Ilana Cass Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Epithelial Cancer | Genetics | Mammography | Mastectomy | Ovarian Cancer | Ovaries | Statistics | Women